SpectraCell Launches NEW Products!

Published on
July 31, 2014

At SpectraCell Laboratories we are always looking for ways to look at the overall health of a patient and in turn providing you with the tools necessary to provide a customized treatment plan where the focus is "Balance is Key" to healthy living.

SpectraCell Laboratories, the leader in functional nutritional testing is proud to announce the launch of our new comprehensive hormone testing and CardioMetabolic with a Pre-diabetes panel to its menu. Below you will find a brief description of each of the tests we are now offering to our clients.    

CARDIOMETABOLIC TESTING

SpectraCell Laboratories, primarily known for its functional nutritional testing, now offers a complete Cardiometabolic Panel to measure risk of heart disease and diabetes.   The new panel, which includes SpectraCell’s advanced Lipoprotein Particle Profile™,   reports several clinically relevant biomarkers in three areas:  (1) Glycemic control  (2) Lipid Metabolism and (3) Vascular Inflammation.  Each patient is given a pre-diabetic risk score ranging from 1 to 8 depending on their results. As a clinician, you can monitor both their specific biomarkers as well as their composite risk and treat accordingly.  Assessing cardiometabolic function is the first step in treating it.

HORMONE TESTING

Complete male and female panels are now available.  Both end-point steroid hormones as well as precursor hormones are included so the precise place of imbalance in the complicated hormonal cascade can be pinpointed.  Several peptide hormones are also included as well as a complete thyroid panel, including thyroid antibody testing.  Like nutrients, an imbalance of one hormone can initiate a cascade of events that alters other hormones, so a comprehensive look at hormone status is essential.

For more information on our new tests or to receive a product guide booklet, complete form.